Join the Obstructive Sleep Apnea/Hypopnea Syndrome group to help and get support from people like you.
Obstructive Sleep Apnea/Hypopnea Syndrome News
Obstructive Sleep Apnea Tied to Poor Outcomes in U.S. Soldiers
WEDNESDAY, July 9, 2025 – Sleep disorders such as obstructive sleep apnea (OSA) contribute to mental health challenges, traumatic injuries, and increased health care utilization in active-duty...
Higher Temperatures Tied to Increased Probability of Obstructive Sleep Apnea
THURSDAY, July 3, 2025 – Higher temperatures across the globe are associated with an increased probability of having obstructive sleep apnea (OSA), according to a study published online June 16 in...
Sleep Apnea Puts Soldiers In Harm's Way
WEDNESDAY, July 2, 2025 — Sleep apnea could be increasing the risks borne by U.S. soldiers serving on the front lines of combat, a new study says. Front-line soldiers are far more likely to suffer P...
Mild Sleep Apnea More Common Among Female Athletes Than Thought
FRIDAY, June 13, 2025 — Sleep apnea could be more common in female college athletes than previously thought, a new study says. Mild sleep apnea was observed in a quarter of a group of 68 female a...
Doctors Favor CPAP, Patients Favor Tirzepatide for Comorbid Obesity, Sleep Apnea
MONDAY, June 9, 2025 – Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with providers favoring...
Wearable Sensor Can Monitor Sleep Apnea Treatment Response
MONDAY, May 19, 2025 – A wearable pulse oximeter and connected software platform (Apnimed) shows promise for monitoring obstructive sleep apnea (OSA) and other sleep-related breathing diseases,...
Apnea During REM May Affect Brain Regions Related to Memory Consolidation
TUESDAY, May 13, 2025 – Greater obstructive sleep apnea (OSA)-related hypoxemia is associated with frontoparietal cerebrovascular pathology, which is linked to reduced medial temporal lobe (MTL)...
Sleep Apnea Linked To Memory-Related Brain Decline
THURSDAY, May 8, 2025 – Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer’s disease, a new study says. The drop in blood oxygen levels that occurs d...
Tonsil Removal Helps Kids With Snoring/Sleep Apnea
THURSDAY, March 20, 2025 – Removing the tonsils and adenoids can improve the sleep of kids with mild breathing problems that disturb their slumber, a new clinical trial reports. Children with sleep...
AAN: Obstructive Sleep Apnea Linked to Increased Incidence of Parkinson Disease
TUESDAY, March 4, 2025 – Obstructive sleep apnea (OSA) is associated with an increased risk for Parkinson disease (PD), according to a study scheduled for presentation at the annual meeting of the...
Tonsillectomy Effective for Nocturnal Enuresis in Children With Sleep Apnea
FRIDAY, Feb. 7, 2025 – For children with obstructive sleep apnea (OSA) with nocturnal enuresis (NE), the remission rate of NE is more than half for those undergoing adenoidectomy and/or...
Sleep Apnea Surgery Linked to Lower Risk for Car Accidents for Patients
TUESDAY, Jan. 28, 2025 – For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for motor vehicle accidents (MVA) compared with continuous...
Does Sleep Apnea Contribute to Car Crashes?
FRIDAY, Jan. 24, 2025 – Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems and diabetes. Add car wrecks to that list, a study...
FDA Approves Zepbound (tirzepatide) as the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity
INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound (tirzepatide) as the first and only...
FDA Approves Zepbound for Sleep Apnea in Patients With Obesity
MONDAY, Dec. 23, 2024 – The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA). In a news...